SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Sales | ₹126 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
What is the latest Revenue of SHREE GANESH REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹126 Cr |
| Mar2024 | ₹6,401,872 Cr |
| Mar2020 | ₹35 Cr |
| Mar2019 | ₹35 Cr |
How is Revenue of SHREE GANESH REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹126 Cr | -100.00 | |
| Mar2024 | ₹6,401,872 Cr | 18,128,325.92 | |
| Mar2020 | ₹35 Cr | 0.00 | |
| Mar2019 | ₹35 Cr | - | |
Compare Revenue of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹622.7 Cr | 8.3% | -1.1% | -35.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 8.3% |
-1.1% |
-35.6% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses